Braidwell LP Has $19.77 Million Stock Position in Harrow, Inc. (NASDAQ:HROW)

Braidwell LP grew its stake in shares of Harrow, Inc. (NASDAQ:HROW) by 47.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 439,638 shares of the company’s stock after purchasing an additional 142,450 shares during the quarter. Braidwell LP’s holdings in Harrow were worth $19,766,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in HROW. Quest Partners LLC acquired a new position in shares of Harrow during the 3rd quarter worth approximately $29,000. nVerses Capital LLC bought a new position in shares of Harrow during the 2nd quarter worth approximately $33,000. Allspring Global Investments Holdings LLC boosted its stake in shares of Harrow by 2,730.7% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,123 shares of the company’s stock worth $44,000 after acquiring an additional 2,048 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Harrow by 21.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,283 shares of the company’s stock worth $57,000 after acquiring an additional 227 shares during the period. Finally, Hills Bank & Trust Co bought a new position in shares of Harrow during the 3rd quarter worth approximately $107,000. Institutional investors and hedge funds own 72.76% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Lake Street Capital lifted their target price on Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, October 4th. Craig Hallum lifted their target price on Harrow from $45.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, October 4th. Finally, B. Riley reiterated a “buy” rating and set a $50.00 target price on shares of Harrow in a research note on Thursday, August 29th.

Harrow Stock Up 0.5 %

HROW opened at $42.47 on Friday. The business has a fifty day simple moving average of $47.68 and a 200 day simple moving average of $34.23. Harrow, Inc. has a 1 year low of $8.72 and a 1 year high of $59.23. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.44 and a current ratio of 1.55.

Harrow Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.